K. Pedersen

发表

Tumor and Stem Cell Biology Constitutive HER 2 Signaling Promotes Breast Cancer Metastasis through Cellular Senescence

R. Gomis, J. Tabernero, J. Arribas, 2012 .

p95HER2 and breast cancer.

J. Baselga, J. Arribas, K. Pedersen, 2011, Cancer research.

p 95 HER 2 and Breast Cancer

J. Arribas, E. Baselga, Jos, 2011 .

The Transcription Factor SLUG Uncouples Pancreatic Cancer Progression from the RAF–MEK1/2–ERK1/2 Pathway

S. Vicent, J. Tabernero, J. Arribas, 2021, Cancer Research.

Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity

J. Baselga, J. Arribas, C. Verma, 2009, Oncogene.

PELO negatively regulates HER receptor signalling and metastasis

J. Tabernero, J. Arribas, F. Canals, 2014, Oncogene.

Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy.

J. Baselga, P. Nuciforo, A. Pandiella, 2014, Journal of the National Cancer Institute.

A Naturally Occurring HER2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and Metastasis

Maurizio Scaltriti, J. Baselga, J. Arribas, 2009, Molecular and Cellular Biology.

A major role of p95/611-CTF, a carboxy-terminal fragment of HER2, in the down-modulation of the estrogen receptor in HER2-positive breast cancers.

J. Baselga, J. Arribas, M. Scaltriti, 2010, Cancer research.

HER2 Fragmentation and Breast Cancer Stratification

J. Arribas, K. Pedersen, J. Parra-Palau, 2010, Clinical Cancer Research.

RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer

A. Green, S. Lemeer, E. Rakha, 2021, Breast Cancer Research.

HER2 Carboxyl-terminal Fragments Regulate Cell Migration and Cortactin Phosphorylation*

J. Baselga, J. Arribas, J. García-Castillo, 2009, The Journal of Biological Chemistry.

Cancer esearch cular and Cellular Pathobiology ajor Role of p 95 / 611-CTF , a Carboxy-Terminal Fragment ER 2 , in the Down-modulation of the Estrogen R eptor in HER 2-Positive Breast Cancers

J. Arribas, M. Scaltriti, S. Y. Cajal, 2010 .

A Naturally Occurring HER 2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and Metastasis †

J. Baselga, J. Arribas, M. Scaltriti, 2009 .

Pancreatic cancer heterogeneity and response to Mek inhibition

J. Tabernero, J. Arribas, A. Vivancos, 2017, Oncogene.

2 Fragmentation and Breast Cancer Stratification

K. Pedersen, J. Parra-Palau, I. Arribas, 2010 .

Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma.

G. Evan, J. Arribas, N. Sodir, 2015, Cancer research.